Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | ESRRG | P62508 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19803812 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HPGDKDM1APGRADRA2A | |
| SCHEMBL12422795 | 0.81 | ALDH1A1 (0.40) | ALDH1A1HPGDPGRADRA2AADRA2B | |
| SCHEMBL12422799 | 0.80 | G6PC1 (0.49) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL2277485 | 0.78 | ALDH1A1 (0.38) | ALDH1A1HPGDPGRADRA2AADRA2B | |
| SCHEMBL11278110 | 0.77 | ALDH1A1 (0.44) | ALDH1A1HPGDPGRADRA2AADRA2B | |
| SCHEMBL11278094 | 0.77 | ALDH1A1 (0.44) | ALDH1A1HPGDPGRADRA2AADRA2B | |
| SCHEMBL19040950 | 0.77 | ALDH1A1 (0.44) | ALDH1A1HPGDPGRADRA2AADRA2B | |
| SCHEMBL8576134 | 0.76 | RECQL (0.45) | ALDH1A1HPGDKDM1AMEN1KMT2A | |
| SCHEMBL12422804 | 0.74 | CYP2C19 (0.43) | MEN1KMT2ASMN1; SMN2CES2CES1 | |
| SCHEMBL11754203 | 0.73 | ALDH1A1 (0.47) | ALDH1A1HPGDMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1064 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025084741-A1 | POLYOLEFIN GRAFT COPOLYMER PRODUCED USING INITIATOR CONTAINING AZIDOFORMATE GROUP AND PRODUCTION METHOD THEREFOR | 세종대학교산학협력단 | 2025-04-24 | — | — | WO | claimed |
| US-20220059846-A1 | BATTERY WITH HALOGEN SEQUESTERING AGENT | GELION TECHNOLOGIES PTY LTD (AU) | 2022-02-24 | — | — | US | claimed |
| EP-3769362-A1 | BATTERY WITH HALOGEN SEQUESTERING AGENT | Gelion Technologies PTY LTD (AU) | 2021-01-27 | — | — | EP | claimed |
| WO-2020051642-A1 | BATTERY WITH HALOGEN SEQUESTERING AGENT | GELION TECHNOLOGIES PTY LTD (AU) | 2020-03-19 | — | — | WO | claimed |
| US-20170298026-A1 | ALL PURPOSE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-10-19 | — | — | US | claimed |
| CN-107108489-A | general RAFT agent | 联邦科学与工业研究组织 | 2017-08-29 | — | — | CN | claimed |
| EP-3204353-A1 | ALL PURPOSE RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-08-16 | — | — | EP | claimed |
| US-20160340463-A1 | PROCESS FOR PREPARING A POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2016-11-24 | — | — | US | claimed |
| CN-103172809-B | The method manufacturing graft copolymer | 固特异轮胎和橡胶公司 | 2016-08-24 | — | — | CN | claimed |
| WO-2016054689-A1 | ALL PURPOSE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-04-14 | — | — | WO | claimed |
| EP-1159318-A2 | OLIGOMERIZATION AND (CO)POLYMERIZATION OF SUBSTITUTED AND UNSUBSTITUTED ALPHA-METHYLENE-GAMMA-BUTYROLACTONES AND PRODUCTS THEREOF | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2001-12-05 | — | — | EP | claimed |
| EP-1149075-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-10-31 | — | — | EP | claimed |
| US-6291620-B1 | Polymer synthesis | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-09-18 | — | — | US | claimed |
| EP-0791016-B1 | POLYMER SYNTHESIS | DU PONT (US) | 2000-07-12 | — | — | EP | claimed |
| WO-2000035960-A2 | OLIGOMERIZATION, POLYMERIZATION AND COPOLYMERIZATION OF SUBSTITUTED AND UNSUBSTITUTED α-METHYLENE-η-BUTYROLACTONES AND PRODUCTS THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-06-22 | — | — | WO | claimed |
| EP-1003793-A1 | FUNCTIONALIZED DIENE OLIGOMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999009077-A1 | FUNCTIONALIZED DIENE OLIGOMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-02-25 | — | — | WO | claimed |
| WO-1999005099-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-04 | — | — | WO | claimed |
| US-5847060-A | Functionalized diene oligomers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-12-08 | — | — | US | claimed |
| EP-0791016-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170298026-A1 | ALL PURPOSE RAFT AGENT | NPC1L1, RFTN1, SGMS2 | ALDH1A1 817/4885HPGD 1750/4885KDM1A 4025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.